A Matsumori Selected Research

A Matsumori Research Topics

Disease

8	Myocarditis (Carditis) 12/2012 - 05/2000
6	Heart Failure 06/2001 - 03/2000
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2001 - 01/2000
5	Infections 05/2012 - 04/2000
4	Cardiomyopathies (Cardiomyopathy) 01/2001 - 01/2000
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 06/2003 - 05/2000
3	Myocardial Infarction 11/2001 - 07/2000
2	Virus Diseases (Viral Diseases) 12/2012 - 02/2008
2	Inflammation (Inflammations) 12/2012 - 12/2000
2	Vascular System Injuries 09/2001 - 12/2000
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2001 - 01/2000
1	Left Ventricular Dysfunction 05/2012
1	Hepatitis 01/2006
1	Liver Diseases (Liver Disease) 09/2005
1	Rupture 11/2001
1	Ventricular Remodeling 11/2001
1	Infarction (Infarctions) 11/2001
1	Neointima 09/2001
1	Hypertension (High Blood Pressure) 06/2001
1	Cardiomegaly (Heart Hypertrophy) 06/2001
1	Sudden Death 01/2001
1	Parasitic Diseases (Parasitic Disease) 01/2001
1	Hyperplasia 12/2000
1	Atherosclerosis 12/2000
1	Carcinoma (Carcinomatosis) 10/2000
1	Thrombosis (Thrombus) 10/2000
1	Unstable Angina 10/2000
1	Collagen Diseases (Collagen Disease) 07/2000
1	Ischemia 07/2000
1	Sarcoidosis (Schaumann Disease) 07/2000
1	Reperfusion Injury 07/2000
1	Hepatitis C 05/2000
1	Muscular Diseases (Myopathy) 04/2000
1	Heart Diseases (Heart Disease) 04/2000

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 12/2012 - 01/2000
5	Troponin T (Troponin T1)IBA 01/2006 - 04/2000
2	Interleukin-10 (Interleukin 10)IBA 07/2001 - 03/2001
2	RNA (Ribonucleic Acid)IBA 07/2000 - 05/2000
2	InterferonsIBA 05/2000 - 04/2000
1	AldosteroneIBA 12/2012
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 12/2012
1	Anti-Allergic Agents (Antiallergic Agents)IBA 12/2012
1	AutoantibodiesIBA 12/2012
1	Mineralocorticoid Receptor AntagonistsIBA 12/2012
1	Troponin IIBA 12/2012
1	Pharmaceutical PreparationsIBA 12/2012
1	ReninIBA 12/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2012
1	Angiotensin Receptor AntagonistsIBA 12/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2012
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2012
1	pro-brain natriuretic peptide (1-76)IBA 05/2012
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2012
1	AntigensIBA 02/2008
1	ThalliumIBA 01/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2005
1	PhytohemagglutininsIBA 05/2002
1	CollagenIBA 11/2001
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2001
1	Protein Sorting Signals (Signal Peptide)IBA 09/2001
1	Becaplermin (PDGF-BB)FDA Link 09/2001
1	NeuropilinsIBA 09/2001
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2001
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2001
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2001
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2001
1	Peptides (Polypeptides)IBA 06/2001
1	SaltsIBA 06/2001
1	FR 167653IBA 06/2001
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2001
1	Therapeutic UsesIBA 05/2001
1	Fingolimod Hydrochloride (FTY720)FDA Link 05/2001
1	Endothelin Receptor AntagonistsIBA 03/2001
1	Endothelin-1 (Endothelin 1)IBA 03/2001
1	Trinitrotoluene (TNT)IBA 01/2001
1	Programmed Cell Death 1 ReceptorIBA 01/2001
1	Cardiac MyosinsIBA 01/2001
1	p38 Mitogen-Activated Protein KinasesIBA 12/2000
1	NF-kappa B (NF-kB)IBA 10/2000
1	ElementsIBA 10/2000
1	LuciferasesIBA 10/2000
1	LipofectamineIBA 10/2000
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2000
1	Peroxidase (Myeloperoxidase)IBA 07/2000
1	HLA-DQB1 antigen (HLA DQB1)IBA 07/2000
1	HLA-DM antigens (HLA-DMA)IBA 07/2000
1	EnzymesIBA 07/2000
1	Formaldehyde (Formol)FDA Link 07/2000
1	Immunoglobulin IsotypesIBA 07/2000
1	Immunoglobulins (Immunoglobulin)IBA 07/2000
1	ImmunosorbentsIBA 07/2000
1	LactoferrinIBA 07/2000
1	AntibodiesIBA 07/2000
1	ParaffinIBA 07/2000
1	Messenger RNA (mRNA)IBA 07/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2000
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2000
1	Indicators and Reagents (Reagents)IBA 04/2000

Therapy/Procedure

3	Therapeutics 07/2001 - 04/2000
1	Immunomodulation 03/2001